Navigation Links
Cardiff scientists study acute infection in end-stage kidney disease patients
Date:11/13/2008

A new research study underway at Cardiff University could see a decrease in the rates of treatment failure among patients with end-stage kidney disease.

Experts in the Infection, Immunity and Inflammation Interdisciplinary Research Group at the School of Medicine have secured more than 230,000 ($375,000) from the 'Renal Discoveries - The Baxter Extramural Grant' program, to investigate the potential to safeguard susceptible patients against serious problems caused by bacterial infections.

Each year Baxter Healthcare Corporation awards the Baxter Extramural Grant for innovation, exploration and application of research to advance the knowledge of renal conditions and its treatment. With only four grants awarded world-wide each year, Cardiff University is the sole recipient of the funding for the Europe/Middle East/Africa and Russia region.

Bacterial infection among patients with end-stage kidney disease is one of the major reasons for treatment failure and mortality, particularly among patients receiving peritoneal dialysis, the form of dialysis that cleans the blood inside the body through the peritoneum.

Now, thanks to the three year funding, the multidisciplinary team sponsored by Professor of Medicine John Williams, at Cardiff University will begin studying the consequence of infection by bacteria in order to understand, and in the future better regulate, a patient's immune response to infections. The team brings together clinicians and researchers at the Peritoneal Dialysis Unit, the Institute of Nephrology, and the Department of Medical Biochemistry and Immunology.

Dr Matthias Eberl, principal investigator at the Department of Medical Biochemistry and Immunology, said: "Although peritoneal dialysis has a number of advantages such as independence from hospital and improved quality of life, infections still pose major risks to the patient. As treatment failure in these patients correlates directly with th
'/>"/>

Contact: Dr Matthias Eberl
eberlm@cardiff.ac.uk
Cardiff University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists Unravel Mystery of Tamoxifen Resistance
2. Freezing Ovaries Preserves Fertility, Scientists Report
3. TSODs Frank Whyte Provides Negotiation Skills Training to NIH Scientists
4. Scientists Debate Dietary Supplements and Cancer Risk at AICR Conference
5. Penn scientists show how body determines optimal amount of germ-fighting B cells
6. Penn scientists map molecular regulation of fat-cell genetics
7. Scientists Make Clones of Mice Dead 16 Years
8. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
9. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
10. Scientists Develop New Strategy to Fight Obesity
11. Scientists Spot 4 New Alzheimers Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way to ... The patent-pending K Med Cups provide a quick and simple way to brew a hot ... flu or cough. As a result, they enhance comfort and health. The invention features a ...
(Date:9/4/2015)... ... 2015 , ... The conference program for the upcoming Integrative ... 2015 at the Diplomat Resort & Spa has been announced and is available ... the top of their field and will be presenting sessions such as What ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... details involving the Pope’s upcoming trip to the United States. , Yisrayl lays out what ... with the Vatican and society is. Yisrayl also provides the meaning of his own name ...
(Date:9/4/2015)... IL (PRWEB) , ... September 04, 2015 , ... Friday ... Geneva, IL hosting Generation Rescue’s A Night of Hope event supporting families affected by ... French and Rowena and Joe Salas, joined together at the Oscar Swan Inn to ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... Jan. 7 Insulet Corporation (Nasdaq: PODD ... OmniPod(R) Insulin Management System, today announced the company will ... Management is scheduled to present an overview of the ... at The Westin St. Francis in San Francisco, CA.During ...
... Beneficiaries Introduced on the First Day of 111th ... Physical therapy services for Medicare beneficiaries would ... under legislation introduced Tuesday in the Senate and ... Therapy Association (APTA). The Medicare Access to Rehabilitation ...
... a statement by Lois Aronstein, AARP NY State Director:Governor ... recommendations on a number of issues that are essential ... Yorkers of all ages.AARP commends the Governor for proposing ... percent of the federal poverty level, making more than ...
... have identified mutations in a gene that predict a ... leukemia (ALL). Although the researchers caution that further research ... called IKZF1 or IKAROS, lead to leukemia relapse, the ... diagnostic tests to assess the risk of treatment failure. ...
... SYK ) announced today that it will participate in the following ... January 14, 2009 -- 10:00 a.m. Pacific Time, ... San Francisco, ... will be available on,Stryker,s website at www.stryker.com via the For Investors ...
... WESTCHESTER, Ill., Jan. 7 BrainLAB, Inc., ... medical treatments,announces a new, customer-focused sales and ... growth and an expanding product,portfolio. , ... and support structures, customers will benefit,from a ...
Cached Medicine News:Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4Health News:Stryker To Present at Investor Conference 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ... on China,s Sodium Ibandronate Market, 2010-2019" report to their ... under the trade name of Bondronat in Germany ... sodium ibandronate was approved by the FDA to come into ... trade name of Boniva. However, since drug makers later developed ...
(Date:9/4/2015)... DUBLIN , Sep. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/dvzsqg/investigation ) has announced the addition ... Sodium Hyaluronate Market, 2010-2019" report to ... a long-chain polymer containing repeating disaccharide units ... synovial fluid and cartilage matrix, sodium hyaluronate ...
(Date:9/4/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("HMP"), its drug R&D subsidiary, successfully achieved the ... of fruquintinib in patients with advanced non-squamous non-small ... .  The top-line results demonstrated that the ... endpoint of progression free survival ("PFS"). ...
Breaking Medicine Technology:Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Investigation Report on China's Sodium Hyaluronate Market 2015 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
... The user-friendly Eppendorf Thermomixer R offers ... that require shaking, heating, and cooling. ... expanded its application and temperature control ... each accommodate 24 micro test tubes, ...
... units Pen.,10k ug Strept. 25 ... Culture Reagent and Buffer products ... cGMP regulations and are cell ... , Typical Properties, Sterility : ...
... Penicillin/25,000 ug Streptomycin All ... Buffer products are manufactured in ... are cell culture tested to ... Sterility : Neg. , pH ...
Medicine Products: